These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 6399890)
21. Disposition and absolute bioavailability of furosemide in healthy males. Waller ES; Hamilton SF; Massarella JW; Sharanevych MA; Smith RV; Yakatan GJ; Doluisio JT J Pharm Sci; 1982 Oct; 71(10):1105-8. PubMed ID: 7143205 [TBL] [Abstract][Full Text] [Related]
22. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]
23. Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect. Alván G; Paintaud G; Eckernäs SA; Grahnén A Br J Clin Pharmacol; 1992 Jul; 34(1):47-52. PubMed ID: 1633067 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium. Wang-Smith L; Fort J; Zhang Y; Sostek M J Clin Pharmacol; 2012 May; 52(5):670-80. PubMed ID: 21628602 [TBL] [Abstract][Full Text] [Related]
25. Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products. Williams BO; Liao SH; Lai AA; Arnold JD; Perkins JG; Blum MR; Findlay JW Clin Pharm; 1984; 3(6):638-43. PubMed ID: 6509877 [TBL] [Abstract][Full Text] [Related]
26. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics. Bramer SL; Forbes WP Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883 [TBL] [Abstract][Full Text] [Related]
27. The relative bioavailability of paracetamol and codeine after oral administration of a combination of buclizine, paracetamol and codeine, with or without docusate, and of paracetamol alone in healthy volunteers. Persaud N; Johnson ES; Merrington D; Oliver W Curr Med Res Opin; 1985; 9(9):626-33. PubMed ID: 2414066 [TBL] [Abstract][Full Text] [Related]
28. Urinary electrolyte excretion after frusemide, amiloride and Frumil: single dose studies. Hamdy RC Br J Clin Pract Suppl; 1985 Jun; 41():13-6. PubMed ID: 3929819 [No Abstract] [Full Text] [Related]
29. An in-vivo-in-vitro correlation for the bioavailability of frusemide tablets. Kingsford M; Eggers NJ; Soteros G; Maling TJ; Shirkey RJ J Pharm Pharmacol; 1984 Aug; 36(8):536-8. PubMed ID: 6148397 [TBL] [Abstract][Full Text] [Related]
30. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers. Ahmad M; Pervaiz F Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997 [TBL] [Abstract][Full Text] [Related]
31. Comparative bioavailability of two furosemide formulations in humans. Martin BK; Uihlein M; Ings RM; Stevens LA; McEwen J J Pharm Sci; 1984 Apr; 73(4):437-41. PubMed ID: 6726624 [TBL] [Abstract][Full Text] [Related]
32. The pharmaceutical and biological availability of commercial preparations of furosemide. Stüber W; Mutschler E; Steinbach D Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics, pharmacodynamics, and comparative bioavailability of single, oral 2-mg doses of dexamethasone liquid and tablet formulations: a randomized, controlled, crossover study in healthy adult volunteers. Queckenberg C; Wachall B; Erlinghagen V; Di Gion P; Tomalik-Scharte D; Tawab M; Gerbeth K; Fuhr U Clin Ther; 2011 Nov; 33(11):1831-41. PubMed ID: 22047811 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis. Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317 [TBL] [Abstract][Full Text] [Related]
35. A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice. Crawford RJ; Allman S; Gibson W; Kitchen S; Richards HH J Int Med Res; 1988; 16(2):143-9. PubMed ID: 3378660 [TBL] [Abstract][Full Text] [Related]
36. Implications of intraindividual variability in bioavailability studies of furosemide. Grahnén A; Hammarlund M; Lundqvist T Eur J Clin Pharmacol; 1984; 27(5):595-602. PubMed ID: 6519165 [TBL] [Abstract][Full Text] [Related]
37. Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation. Kakuda TN; Leopold L; Timmers M; Van De Casteele T; Hillewaert V; Tomaka FL; Hoetelmans RM Int J Clin Pharmacol Ther; 2014 Sep; 52(9):805-16. PubMed ID: 25109510 [TBL] [Abstract][Full Text] [Related]
38. The short and long term effects of a frusemide/amiloride combination tablet (Frumil) on plasma electrolytes. Norris RJ Br J Clin Pract Suppl; 1985 Jun; 41():4-12. PubMed ID: 3929822 [No Abstract] [Full Text] [Related]
39. Different effects of inhaled amiloride and frusemide on airway responsiveness to dry air challenge in asthmatic subjects. Rodwell LT; Anderson SD; du Toit J; Seale JP Eur Respir J; 1993 Jun; 6(6):855-61. PubMed ID: 8339806 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects. Cho HY; Yoon H; Lim YC; Lee YB Int J Clin Pharmacol Ther; 2009 Dec; 47(12):770-9. PubMed ID: 19954716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]